Overall, both the RB1-defective and RBness groups constituted predominantly aggressive subtypes of breast cancer [PAM50 (37): Basal-like and HER2-enriched] compared to the RBNSig-low group, which was composed of Luminal subtypes (Fig. 2F). The gene discussed is ERBB2; the disease is breast cancer.